BlackRock Fund Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $328K | Sell |
2,068
-1,583
| -43% | -$251K | ﹤0.01% | 3310 |
|
|
2016
Q3 | $905K | Buy |
3,651
+340
| +10% | +$84.3K | ﹤0.01% | 3233 |
|
|
2016
Q2 | $2.96M | Buy |
3,311
+36
| +1% | +$32.1K | ﹤0.01% | 3082 |
|
|
2016
Q1 | $2.98M | Buy |
3,275
+101
| +3% | +$91.8K | ﹤0.01% | 2963 |
|
|
2015
Q4 | $4.48M | Buy |
3,174
+1,680
| +112% | +$2.37M | ﹤0.01% | 2890 |
|
|
2015
Q3 | $2.51M | Sell |
1,494
-10
| -0.7% | -$16.8K | ﹤0.01% | 3068 |
|
|
2015
Q2 | $3.24M | Buy |
1,504
+451
| +43% | +$972K | ﹤0.01% | 3082 |
|
|
2015
Q1 | $1.93M | Buy |
1,053
+50
| +5% | +$91.5K | ﹤0.01% | 3137 |
|
|
2014
Q4 | $2.39M | Buy |
+1,003
| New | +$2.39M | ﹤0.01% | 3133 |
|